MET expression	Gastroesophageal Junction Adenocarcinoma	MET expression	Gastroesophageal Junction Adenocarcinoma	AMG 102 Resistant: B - Late Trials AMG 102 Resistant : B	AMG 102 Resistant: B - Late Trials AMG 102 Resistant : B
MET expression	Gastric Adenocarcinoma	MET expression	Gastric Adenocarcinoma	AMG 102 Resistant: B - Late Trials AMG 102 Resistant : B	AMG 102 Resistant: B - Late Trials AMG 102 Resistant : B
MET expression	Solid Tumor	MET expression	Solid Tumor	BYON3521 Sensitive: C2 – Inclusion Criteria BYON3521 Sensitive : C2	BYON3521 Sensitive: C2 – Inclusion Criteria BYON3521 Sensitive : C2
MET expression	Hepatocellular Cancer	MET expression	Hepatocellular Cancer	sorafenib Sensitive: D – Preclinical sorafenib Sensitive : D	sorafenib Sensitive: D – Preclinical sorafenib Sensitive : D
MET expression	Non Small Cell Lung Cancer	MET expression	Non Small Cell Lung Cancer	entrectinib Resistant: D – Preclinical entrectinib Resistant : D	entrectinib Resistant: D – Preclinical entrectinib Resistant : D
MET expression	Renal Cell Carcinoma	MET expression	Renal Cell Carcinoma	sunitinib Sensitive: D – Preclinical sunitinib Sensitive : D	sunitinib Sensitive: D – Preclinical sunitinib Sensitive : D
MET expression	Solid Tumor	MET expression	Solid Tumor	MYTX-011 Sensitive: D – Preclinical MYTX-011 Sensitive : D	MYTX-011 Sensitive: D – Preclinical MYTX-011 Sensitive : D
MET expression	Non Small Cell Lung Cancer	MET expression	Non Small Cell Lung Cancer	REGN5093-M114 Sensitive: D – Preclinical REGN5093-M114 Sensitive : D	REGN5093-M114 Sensitive: D – Preclinical REGN5093-M114 Sensitive : D
MET expression	Colorectal Cancer	MET expression	Colorectal Cancer	HRA00129-C004 Sensitive: D – Preclinical HRA00129-C004 Sensitive : D	HRA00129-C004 Sensitive: D – Preclinical HRA00129-C004 Sensitive : D
MET expression	Gastric Cancer	MET expression	Gastric Cancer	HRA00129-C004 Sensitive: D – Preclinical HRA00129-C004 Sensitive : D	HRA00129-C004 Sensitive: D – Preclinical HRA00129-C004 Sensitive : D
MET expression	Lung Cancer	MET expression	Lung Cancer	HRA00129-C004 Sensitive: D – Preclinical HRA00129-C004 Sensitive : D	HRA00129-C004 Sensitive: D – Preclinical HRA00129-C004 Sensitive : D
MET expression	Ovarian Cancer	MET expression	Ovarian Cancer	ABSK091 Sensitive: D – Preclinical ABSK091 Sensitive : D	ABSK091 Sensitive: D – Preclinical ABSK091 Sensitive : D

MET expression

Associations